Latest news with #CBIZ
Yahoo
6 days ago
- Business
- Yahoo
1 Services Stock for Long-Term Investors and 2 to Ignore
Business services providers thrive by solving complex operational challenges for their clients, allowing them to focus on their secret sauce. Still, investors are uneasy as firms face challenges from AI-driven disruptors and tightening corporate budgets. These doubts have caused the industry to lag recently as services stocks have collectively shed 10.9% over the past six months. This drawdown was worse than the S&P 500's 1.9% decline. Only some companies are subject to these dynamics, however, and a handful of high-quality businesses can deliver earnings growth in any environment. Taking that into account, here is one resilient services stock at the top of our wish list and two we're passing on. Market Cap: $15.1 billion With a workforce of approximately 45,000 professionals tackling complex challenges from water scarcity to cybersecurity, Jacobs Solutions (NYSE:J) provides engineering, consulting, and technical services focused on infrastructure, sustainability, and advanced technology solutions. Why Do We Pass on J? Flat sales over the last two years suggest it must find different ways to grow during this cycle Sales pipeline suggests its future revenue growth likely won't meet our standards as its backlog hasn't budged over the past two years Performance over the past five years shows its incremental sales were much less profitable, as its earnings per share fell by 9.6% annually Jacobs Solutions is trading at $125.84 per share, or 19.6x forward P/E. Dive into our free research report to see why there are better opportunities than J. Market Cap: $3.85 billion With over 120 offices across 33 states and a team of more than 6,700 professionals, CBIZ (NYSE:CBZ) provides accounting, tax, benefits, insurance brokerage, and advisory services to help small and mid-sized businesses manage their finances and operations. Why Does CBZ Give Us Pause? Free cash flow margin dropped by 10.2 percentage points over the last five years, implying the company increased its investment activities to fend off competitors Below-average returns on capital indicate management struggled to find compelling investment opportunities 6× net-debt-to-EBITDA ratio shows it's overleveraged and increases the probability of shareholder dilution if things turn unexpectedly CBIZ's stock price of $72 implies a valuation ratio of 18.9x forward P/E. To fully understand why you should be careful with CBZ, check out our full research report (it's free). Market Cap: $2.32 billion Founded in 2002 during a time of significant regulatory change in corporate America, Huron Consulting Group (NASDAQ:HURN) is a professional services company that helps organizations develop growth strategies, optimize operations, and implement digital transformation solutions. Why Do We Like HURN? Market share has increased this cycle as its 13.1% annual revenue growth over the last two years was exceptional Adjusted operating margin expanded by 8.6 percentage points over the last five years as it scaled and became more efficient Share repurchases have amplified shareholder returns as its annual earnings per share growth of 34.6% exceeded its revenue gains over the last two years At $145.25 per share, Huron trades at 19.7x forward P/E. Is now the right time to buy? See for yourself in our in-depth research report, it's free. The market surged in 2024 and reached record highs after Donald Trump's presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025. While the crowd speculates what might happen next, we're homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver's seat and build a durable portfolio by checking out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today for free. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
27-05-2025
- Business
- Yahoo
CBIZ and ePlus Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +2.0%, S&P 500 +1.5%) as President Trump postponed the planned 50% tariff on European Union imports, shifting the start date to July 9, 2025. Companies with substantial business ties to Europe likely had some relief as the delay reduced near-term cost pressures and preserved cross-border demand. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Among others, the following stocks were impacted: Business Process Outsourcing & Consulting company CBIZ (NYSE:CBZ) jumped 5%. Is now the time to buy CBIZ? Access our full analysis report here, it's free. IT Distribution & Solutions company ePlus (NASDAQ:PLUS) jumped 5.5%. Is now the time to buy ePlus? Access our full analysis report here, it's free. ePlus's shares are somewhat volatile and have had 10 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. The previous big move we wrote about was 4 days ago when the stock gained 7% on the news that the company reported decent first quarter 2025 earnings. EPS beat handily while revenue missed. Notably, margins improved, thanks to a shift toward higher-margin services like software subscriptions and managed support. But looking ahead, the company initiated full-year fiscal 2026 guidance (since fiscal year 2025 ended in March), guiding to "net sales growth of low single digits, and gross profit and adjusted EBITDA in the mid single digits". This was below expectations of mid single digit revenue growth and double digit EBITDA growth. Overall, this was a mixed yet decent quarter. ePlus is down 5.8% since the beginning of the year, and at $69.70 per share, it is trading 31.4% below its 52-week high of $101.67 from October 2024. Investors who bought $1,000 worth of ePlus's shares 5 years ago would now be looking at an investment worth $1,874. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Reuters
22-05-2025
- Business
- Reuters
What you need to know about the SALT deduction in Trump's tax bill
NEW YORK, May 22 (Reuters) - Affluent earners who live in states with high property and income taxes may see some relief in President Donald Trump's tax plan. The Republican-led U.S. House of Representatives passed a bill on Thursday that would allow a deduction of up to $40,000 on federal returns for state and local taxes, known as SALT. A previous version of the bill had a cap of $30,000. If passed by the Senate, the new expanded SALT cap would benefit millions of big earners in high-tax states, including New York, New Jersey, Pennsylvania, Maryland, Oregon and California. Since new tax laws in 2017, the SALT deduction has been capped at $10,000. Changes could go into effect for the 2025 tax year, so taxpayers who itemize their deductions could reap bigger returns as early as next year. "If you live in a state with high taxes and make between $200,000 to $500,000, we estimate that it will probably increase after-tax income by nearly 1%," said Ernie Tedeschi, director of economics at The Budget Lab at Yale, a nonpartisan think tank. Lisa Lewis, a certified public accountant and tax expert with TurboTax in San Diego, said upper-income earners had been missing the valuable deduction for property and state income. "Will it move the needle financially? It will help," she said. In its current iteration, the SALT cap would increase by 1% per year through 2033, said Mark Baran, a tax attorney and managing director at CBIZ in Washington, DC. Baran said that many of the people with the most to gain from the SALT deduction live in so-called blue, or Democratic-leaning, states. For everyone else, he said "the distributional effect is unclear." For some residents of high-tax coastal states, this could bring some welcome financial relief. "But it doesn't change that fact that truly high earners are making geographic moves due to tax law," said Eric D. Brotman, a certified financial planner and chief executive officer of BFG Financial Advisors. The tax bill is likely to be altered as it moves its way through the legislative process and some tax experts told Reuters they expect the Senate to tweak parts of the proposed SALT deductions to bring down the cost.
Yahoo
22-05-2025
- Business
- Yahoo
NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF GRANT THORNTON LLP AS ITS INDEPENDENT AUDITOR
HOUSTON, May 22, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced the appointment of Grant Thornton LLP ("Grant Thornton") as the Company's independent registered public accounting firm to replace CBIZ CPAs ("CBIZ"), effective May 15, 2025. The change of the Company's independent auditor was made after careful consideration and an evaluation process and was approved by the Audit Committee and the Board of Directors of the Company. The decision to change auditors was not as a result of any disagreement between the Company and CBIZ on any matter of accounting principles or practices, financial statement disclosure, auditing scope or procedures. The Company is working closely with CBIZ and Grant Thornton to ensure a seamless transition. "Building on our great momentum and steadily increasing market cap, and also as part of the Company's commitment to best corporate governance practices, our Board of Directors believed it was a good time to change auditors. We would like to extend our gratitude to CBIZ for their expertise and quality audit services provided to the Company over many years," stated Jon Bates, Chief Financial Officer of Nutex Health. About Nutex Health Inc. Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a healthcare management and operations company with two divisions: a Hospital Division and a Population Health Management Division. The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 24 facilities in 11 states. The Population Health Management division owns and operates provider networks such as Independent Physician Associations (IPAs). Through our Management Services Organization (MSO), we provide management, administrative and other support services to our affiliated hospitals and physician groups. Forward-Looking Statements Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will", "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including the interim final and final rules implemented under the No Surprises Act , economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Annual Report on Form 10-K for the year ended December 31, 2024, under the heading "Risk Factors" in Part II, Item IA thereof, and the risk factors and other cautionary statements contained in our other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release. View original content: SOURCE Nutex Health, Inc.
Yahoo
20-05-2025
- Business
- Yahoo
CBIZ Report Highlights Rising Costs: Surge in Inpatient and Outpatient Expenses, Popular GLP-1 Drugs like Ozempic Drive Pharmacy Spend Increase
New CBIZ State of Healthcare Report Reveals Cost Increases, Significant Impact of GLP-1 Drugs on Pharmacy Spend, and Regulatory Changes Expanding Employee Protections and Accessibility CLEVELAND, May 20, 2025--(BUSINESS WIRE)--CBIZ, Inc. (NYSE: CBZ), a leading national professional services advisor, announced the release of its 2025 State of Healthcare Report. The report provides a data-driven look at trends affecting employer-sponsored healthcare and the strategies organizations are using to stay competitive. Now, more than ever, employers face increased pressure to balance affordability with employee wellbeing as healthcare costs continue to rise. The State of Healthcare Report draws on CBIZ's proprietary data from more than 290,000 plan members, delivering insights into care delivery, cost containment, and regulatory compliance. Key insights from the report: Healthcare costs continue to rise, with CBIZ data finding that cost per visit for inpatient, outpatient, and professional care increased from 2022 to 2024. CBIZ data shows that GLP-1s are a significant cost driver in employers' pharmacy spend. GLP-1 spend as a percentage of overall pharmacy spend has increased from 9% in 2022 to 17% in 2024. This trend is expected to continue as these medications grow in popularity. Ongoing regulatory changes, specifically those occurring at the state level, are shifting employer-sponsored healthcare. Many of these regulations expand protections and accessibility for employees, and employers must continue to monitor relevant legislation to maintain compliance. "Healthcare has never been more complex than it is right now," said Cole Harris, Business Unit President, National Practice Leader for Health Innovations. "The report is designed to give employers real data-driven insights and forward-looking guidance to navigate our increasingly complex environment." The State of Healthcare Report provides a high-level overview of emerging risks and opportunities, featuring analysis from our experts on how to proactively tackle these challenges through data, innovation, and smarter benefits design. To download the full report, visit 2025 State of Healthcare Report About CBIZ CBIZ, Inc. (NYSE: CBZ) is a leading professional services advisor to middle market businesses and organizations nationwide. With unmatched industry knowledge and expertise in accounting, tax, advisory, benefits, insurance, and technology, CBIZ delivers forward-thinking insights and actionable solutions to help clients anticipate what's next and discover new ways to accelerate growth. CBIZ has more than 10,000 team members across more than 160 locations in 22 major markets coast to coast. For more information, visit View source version on Contacts Media: Amy McGahan, Director of Corporate & Strategic Communications, Sign in to access your portfolio
